Cargando…
Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena
Neprilysin (NEP) is a transmembrane zinc‐dependent metalloproteinase that inactivates various peptide hormones including glucagon‐like peptide 1 (GLP‐1). NEP inhibitors may be effective in the management of type 2 diabetes mellitus (T2DM) by increasing the circulating level of GLP‐1. However, acute‐...
Autores principales: | AlAnazi, Faisal Holil, Al‐kuraishy, Hayder M., Al‐Gareeb, Ali I., Alexiou, Athanasios, Papadakis, Marios, Ogaly, Hanan A., Alanazi, Yousef Abud, Saad, Hebatallah M., Batiha, Gaber El‐Saber |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172023/ https://www.ncbi.nlm.nih.gov/pubmed/37078106 http://dx.doi.org/10.1111/1753-0407.13389 |
Ejemplares similares
-
Primary Hypothyroidism and Alzheimer’s Disease: A Tale of Two
por: AlAnazi, Faisal Holil, et al.
Publicado: (2023) -
The potential role of scavenger receptor B type I (SR‐BI) in SARS‐CoV‐2 infection
por: Alkazmi, Luay, et al.
Publicado: (2023) -
The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
por: Alrouji, Mohammed, et al.
Publicado: (2023) -
NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
por: Alrouji, Mohammed, et al.
Publicado: (2023) -
New insights on the potential effect of vinpocetine in Parkinson’s disease: one of the neglected warden and baffling topics
por: Al-kuraishy, Hayder M., et al.
Publicado: (2023)